Creating a new eye drop treatment for healing corneal injuries
Development of a Peptide Therapy for Corneal Wound Healing
This study is testing a new eye drop treatment designed to help heal common eye injuries faster, like scratches or infections, and it's aimed at helping people get back to their daily activities more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Viso Therapeutics INC. NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10484711 on NIH RePORTER |
What this research studies
This research focuses on developing a novel peptide-based eye drop therapy aimed at accelerating the healing of common corneal injuries, such as abrasions and infections. The approach involves testing the effectiveness of this new treatment in animal models to ensure it works effectively before moving to human trials. By using a unique mechanism of action, this therapy aims to reduce recovery time and improve patients' ability to perform daily activities. The research also seeks to establish the best application methods for the drug to maximize its benefits.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing acute corneal injuries, such as abrasions or infections.
Not a fit: Patients with chronic corneal conditions or those who do not have acute injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce healing time for corneal injuries, leading to improved vision and quality of life for patients.
How similar studies have performed: While peptide therapies are a novel approach in this context, similar strategies have shown promise in other areas of wound healing and ocular treatments.
Where this research is happening
Chicago, United States
- Viso Therapeutics INC. — Chicago, United States (Active)
Researchers
- Principal investigator: Flavin, Michael — Viso Therapeutics INC.
- Study coordinator: Flavin, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.